Get started
Work

MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit.

Year: 2020
Type: article
Study design: Clinical Trial
DOI: 10.1016/s0959-8049(20)31084-4
Authors: J. Sampson, A.S. Achrol, M.K. Aghi, K. Bankiewicz, M. Bexon, S. Brem, A. Brenner, S. Chowdhary, M. Coello, B.M. Ellingson, J.R. Floyd, S. Han, S. Kesari, F. Merchant, N. Merchant, D. Randazzo, M. Vogelbaum, F. Vrionis, M. Zabek, N. Butowski
Institutions: Duke Medical Center, Loma Linda University Medical Center, University of California, San Francisco, The Ohio State University Wexner Medical Center, The Ohio State University, Hospital of the University of Pennsylvania, The University of Texas at San Antonio Health Science Center, Boca Raton Regional Hospital, University of California, Los Angeles, Oregon Health & Science University, Moffitt Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: closed
OpenAlex ID: W3096435966
FWCI:
Cites:
Cited by:
Related to: 10